Computer Aided Detection Market Report 2024 (Global Edition)

MARKET DYNAMICS

KEY DRIVERS

• Growing consciousness about the value of early cancer diagnosis is supporting market expansion

In recent years, there has been a rise in cancer cases worldwide. The primary reasons for this increase in the cases are lifestyle, eating habits, hereditary, etc. According to World Cancer Research Fund International, in 2020, there were projected to be 18.1 million cases of cancer worldwide. Men accounted for 9.3 million of these instances, while women made for 8.8 million. The most prevalent cancers globally in 2020 were lung and breast cancers, which accounted for 12.2% and 12.5% of all newly diagnosed cases, respectively. In 2020, colorectal cancer accounted for 10.7% of all new cases and was the third most frequent cancer with 1.9 million new cases. An early diagnosis increases the likelihood of a favourable outcome for cancer treatment since the tumor is still manageable and has not spread. For instance, according to Cancer Research UK, nearly all women with breast cancer survive the disease for five years or longer if it is discovered at the earliest stage. About 3 out of 10 women will have breast cancer when it is discovered at its most advanced state. Nonetheless, six out of ten lung cancer patients who are diagnosed within the first five years of their illness go on to live for five years or more. When lung cancer is discovered at its most advanced stage, less than 1 in 10 patients fall into this category.

Due to this, the awareness regarding the early diagnoses of cancer has spread worldwide. The computer-aided detection with this advanced software and technology allows for full body X-ray, detection, screening, etc of a body, which allows for easy and early symptoms or building up of any cancer in the body. There have also been various initiatives that are undertaken to promote early awareness of cancer. For instance. The Apollo Cancer Centre in India initiated a breast cancer diagnosis program in November 2023 to offer prompt and precise diagnoses. The program emphasizes the significance of early detection in choosing appropriate treatments for a better chance of survival and enhanced quality of life. Therefore, the increasing awareness about early cancer diagnosis will allow the market for computer-aided detection to expand.

(Source:https://www.wcrf.org/cancer-trends/worldwide-cancer-data/, https://www.cancerresearchuk.org/about-cancer/.,  https://www.apollohospitals.com/apollo-news/apollo-cancer-centre-introduces-indias-fastest-and-most-precise-breast-cancer-diagnosis-program-redefining-cancer-care/) 

• Increased expenditures in R&D for 3D imaging are favoring market growth

In recent years many companies have been investing in 3D imaging. 3D imaging is the process of creating a three-dimensional image that appears to have depth. Two or more motion cameras are utilized to capture a three-dimensional object and produce these 3D pictures. High-resolution images are created through the integration of 3D image sensors, cameras, and screens. 3D imaging technologies offer a distinct advantage in medical practice, ranging from improving diagnostic precision to offering surgical guidance. Complex medical data can be decrypted by 3D imaging, leading to more effective and individualized treatment. Enhanced 3D imaging techniques improve the detection rates of CAD systems and provide more detailed and accurate images of the region of interest, especially in the context of medical diagnostics. The market is expanded by the new uses for CAD systems, which include cancer, orthopaedics, and dentistry, thanks to advancements in 3D imaging. The long-term benefits include fewer diagnostic errors, improved workflow efficiency, and potentially fewer errors overall, even though the initial deployment and R&D costs are high. Consequently, there may be growth in the market for computer-aided detection.

RESTRAINT 

• The high expense of computer-aided detection equipment and the scarcity of qualified personnel might limit market growth

The high price of computer-aided detection (CAD) technology and the shortage of trained labor, particularly in the field of cancer therapy, present significant challenges for the healthcare industry. CAD systems are extremely helpful in assisting medical professionals in accurately diagnosing and treating various forms of cancer. However, many healthcare institutions are put off by the substantial investment required to purchase and maintain CAD equipment, particularly those in resource-constrained situations. For instance, the cost of an X-ray machine comes between 3,25,000-8,00,000 based on the brand, features, size, and type. A shortage of qualified staff further exacerbates this issue. Proper use of CAD technology is hampered in the field of cancer therapy by a shortage of skilled experts, where immediate action and precise diagnosis are critical. Qualified medical staff are essential to ensuring patients receive the right care and comprehend scan results. For instance, according World Health Organisation (WHO) and the Bureau of Labour Statistics (BLS) make it clear that there is a worldwide shortage of healthcare professionals, particularly in specialist fields like oncology. This shortage is expected to increase over the next several years, which will significantly complicate the application of CAD technology for cancer diagnosis and treatment. With all factors considered, even though computer-aided detection has great potential to improve the effectiveness and efficiency of cancer diagnosis and treatment, the high equipment costs and shortage of qualified professionals are major obstacles to its widespread adoption and use in the healthcare sector.

How the COVID-19 impact global computer-aided detection?

COVID-19 has resulted in a plethora of rigorous regulations and limitations from the government, which have hurt the healthcare sector. Lockdown regulations prevented many patients from visiting hospitals, diagnostic centers, and research facilities for the diagnosis of cancers related to the brain, musculoskeletal system, heart, colon, prostate, liver, breast, lung, or other organs. The market for computer-aided detection (CAD) suffered as a result. With a projected 10 million fatalities in 2020—or one in six deaths—cancer was one of the world's major causes of death, according to the World Health Organization. In addition, compared to the general population, cancer patients were more susceptible to infection. The hospital capacity problem and unforeseen limitations were two of the reasons behind the demise of the computer-aided detection sector. However, when the number of COVID-19 cases rose, computer-aided detection devices were employed to identify patients infected with the virus. The gadget was used to make sure that COVID-19 patients were accurately identified according to the technological advancements it offers. After adjustments were made to the computer-aided identification software and algorithm, the devices were used in X-rays, photo screening, and other procedures to identify the proper image and patients who were diagnosed with COVID-19. These allowed for the market to grow. For instance, NCBI research described a computer-aided detection technique that uses pictures from chest X-rays to fight the epidemic. The model was developed by combining several pre-trained networks. Thus, in the beginning, the global computer-aided detection market saw a decline in its market but eventually with needs in the healthcare, its usage increased. (Souce: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668604/) 
 

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Computer Aided Detection Market is witnessing significant growth in the near future.

In 2023, the Oncology segment accounted for noticeable share of global Computer Aided Detection Market and is projected to experience significant growth in the near future.

The Mammograph segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Siemens Healthineers AG (Germany) , GE HealthCare Technologies Inc. (U.S.) and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions (FAQs)